KR890003811B1 - Process for preparing n-(2-pyrimidyl) piperazinyl derivatives - Google Patents
Process for preparing n-(2-pyrimidyl) piperazinyl derivatives Download PDFInfo
- Publication number
- KR890003811B1 KR890003811B1 KR1019870005273A KR870005273A KR890003811B1 KR 890003811 B1 KR890003811 B1 KR 890003811B1 KR 1019870005273 A KR1019870005273 A KR 1019870005273A KR 870005273 A KR870005273 A KR 870005273A KR 890003811 B1 KR890003811 B1 KR 890003811B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- preparing
- pyrimidyl
- cpd
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
본 발명은 비습관 신경안정제로 알려진 다음 일반식(I)의 화합물 N-(2-피리미딜)피페라지닐 알킬아자스피로 알칸디온과 그염의 신규 제조방법에 관한 것이다.The present invention relates to a novel process for the preparation of the compound N- (2-pyrimidyl) piperazinyl alkylazaspiro alkanedione and salts of the following general formula (I), known as non- habitual neurostabilizers.
상기 일반식(I)로 나타낸 화합물은 공지된 화합물로서 미국특허 3,717,634에서와 같이 첫째, 8-옥사스피로[4.5]데칸-7,9-디온과1-(4-아미노부틸)-4-(2-피리미딜)피페라진을 피리딘 용매하에서 장시간 환류시키는 방법, 둘째, 8-(4-할로-1-부틸)-8-아자스피로[4.5]데칸-7,9-디온과N-(2-피리미딜)피페라진을 장시간 반응시키는 방법등이 소개되고 있으나, 첫째반응은, 반응시 하프아미드의 생성은 쉽게되나 그 다음 반응이 완결되려면 높은 온도나 상당한 시간이 필요하게 되는 단점이 있으며, 둘째반응은 8-(4-할로-1-부틸)-8-아자스피로[4.5]데칸-7,9-디온 제조시 부반응으로 중합체의 생성 가능성이 있어 수율이 낮고 정제가 어려우므로 경제적인 방법이 되지 못한다. 그러나, 본 발명은 상기 일반식(I) 화합물을 제조함에 있어서 종래의 제조방법과는 다른 신규 화합물인 다음 일반식(IV) 화합물을 이용하여 일반식(V) 화합물과 반응시켜 제조하는 방법으로 온화한 조건에서 단시간내에 반응이 완결되어 고순도의 목적물을 높은 수율로 얻을 수 있는 새로운 합성방법을 제공한다. 본 발명은 일반식(Ⅱ)인 8-아자스피로[4.5]데칸-7,9-디온이나 그것의 무기염을 일반식(Ⅲ)인 알킬클로로포름에이트와 반응시켜 신규 화합물인 일반식(Ⅳ)의 8-카보알콕시-8-아자스피로[4.5]데칸-7,9-디온을 높은 수율로 쉽게 제조하고 이것을 구조식(Ⅴ)의 화합물인 1-(4-아미노부틸)-4(2-피리미딜)-피페라진과 반응시켜 낮은 온도에서 단시간내 높은 수율로 일반식(I) 화합물을 제조하는 방법이다.The compound represented by formula (I) is a known compound, as in US Pat. No. 3,717,634. First, 8-oxaspiro [4.5] decane-7,9-dione and 1- (4-aminobutyl) -4- (2 -Pyrimidyl) piperazine in a pyridine solvent for a long time reflux, second, 8- (4-halo-1-butyl) -8-azaspiro [4.5] decane-7,9-dione and N- (2-pyrid Although a method of reacting midi) piperazine for a long time has been introduced, the first reaction has the disadvantage of easily generating halfamide in the reaction, but requires a high temperature or a considerable time for the reaction to be completed. In the preparation of 8- (4-halo-1-butyl) -8-azaspiro [4.5] decane-7,9-dione, there is a possibility of formation of a polymer by side reaction, and thus it is not economical method because of low yield and difficult purification. However, the present invention is gentle in the method of preparing the compound of the general formula (I) by reacting with the compound of the general formula (V) using the following compound of the general formula (IV), which is different from the conventional production method. The reaction is completed in a short time under the conditions to provide a new synthesis method to obtain a high-purity target in high yield. The present invention reacts 8-azaspiro [4.5] decane-7,9-dione of the general formula (II) or its inorganic salt with alkylchloroformate of the general formula (III) to give a new compound of general formula (IV). 8-Carboalkoxy-8-azaspiro [4.5] decane-7,9-dione is readily prepared in high yield and is a compound of formula (V) 1- (4-aminobutyl) -4 (2-pyrimidyl) It is a method for preparing the compound of general formula (I) in high yield in a short time by reacting with piperazine at low temperature.
본 발명의 제조공정을 도식하면 다음과 같다.The manufacturing process of the present invention is as follows.
(상기식중 M은 H, 또는 Na, K와 같은 알칼리 금속을 나타내며, R은 메틸, 에틸등의 저급알킬그룹 또는 벤질그룹을 나타냄)(Wherein M represents an alkali metal such as H, or Na, K, and R represents a lower alkyl group or benzyl group such as methyl or ethyl)
본 발명은 좀더 상세히 설명하면 상기 일반식(Ⅱ) 화합물은 일반적인 방법에 따라 수산화나트륨, 수산화칼륨, 소디움메톡시드와 반응시켜 쉽게 제조할 수 있으며 이때 용매로는 사용하는 염기의 종류에 따라 알코올류, 아세톤, 메틸렌 또는 에틸렌 클로라이드와 같은 할로겐 알칸류가 가능하다.When the present invention is described in more detail, the general formula (II) compound can be easily prepared by reacting with sodium hydroxide, potassium hydroxide, sodium methoxide according to a general method, and as a solvent, alcohols, Halogen alkanes such as acetone, methylene or ethylene chloride are possible.
본 발명의 신규물질인 구조식(Ⅳ) 화합물을 제조하기 위하여 구조식(Ⅱ) 화합물과 구조식(Ⅲ) 화합물의 반응몰비는 1 : 1.0-1.5당량을 사용하는 것이 바람직하며, 용매로서는 벤젠, 톨루엔, 키실렌등의 방향족 탄화수소, 메틸렌·에틸렌 클로라이드와 같은 할로겐알칸류, N, N-디메틸포름아미드, N, N-디메틸아세트아미드, 디메틸설폭시드, 디옥사, 테트라하이드로푸란등과 이들의 혼합용매가 가능하다. 용매에 따라서 -5℃ 내지 환류온도 범위내에서 1시간 내지 3시간내에 반응이 거의 완결되며, 이때 트리에틸아민, 디메틸아민등과 같은 염기를 촉매량 내지 1.0당량을 사용하면 반응이 빠르게 진행된다. 그리고 본 발명의 목적물인 구조식(Ⅰ)의 제조는 구조식(Ⅳ)와 구조식(Ⅴ)을 화합물을 물, 알코올류, 아세토니트릴, 테트라하이드로푸란, 디옥산, N, N-디메틸포름아미드, N, N-디메틸아세트아미드, 디메틸설폭시드등의 용매로 사용하여 실온 내지 100℃ 범위내에서 10시간 내에 반응이 거의 완결되어 높은 수율과 순도로 먹적화합물을 분리 정제할 수 있다. 이때 탄산나트륨, 탄산칼륨, 트리에틸아민, 디메틸아민등의 염기를 촉매량 내지 1.0당량 사용하면 반응이 빠르게 진행되며, 용매로서 N, N-디메틸포름아미드, 아세트아미드, 디메틸설폭시드등을 사용하는 것이 더욱 바람직하다. 다음의 실시예는 본 발명을 명확하게 이해하고 실시할 수 있도록 하기위한 것이지 본 발명을 한정하기 위한 것은 아니다. NMR 스펙트럼은 80MHz(Bruker)스펙트로미터를 사용하여 기록하였고 화학적이동(Shift)은 델타(ppm)로 나타내었다.In order to prepare the compound of formula (IV), which is a novel substance of the present invention, the reaction molar ratio of the compound of formula (II) to the compound of formula (III) is preferably 1: 1.0-1.5 equivalents. As a solvent, benzene, toluene, key Aromatic hydrocarbons such as styrene, halogen alkanes such as methylene ethylene chloride, N, N-dimethylformamide, N, N-dimethylacetamide, dimethyl sulfoxide, dioxa, tetrahydrofuran and the like and a mixed solvent thereof are possible Do. Depending on the solvent, the reaction is almost completed within 1 hour to 3 hours in the range of -5 ° C to reflux temperature. At this time, if a base such as triethylamine, dimethylamine or the like is used in a catalytic amount to 1.0 equivalent, the reaction proceeds rapidly. The preparation of Structural Formula (I), which is an object of the present invention, is carried out using the compounds of Formula (IV) and Structural Formula (V) with water, alcohols, acetonitrile, tetrahydrofuran, dioxane, N, N-dimethylformamide, N, Using as a solvent such as N-dimethylacetamide, dimethyl sulfoxide and the like, the reaction is almost completed within 10 hours at room temperature to 100 ° C., and the purified compound can be separated and purified in high yield and purity. At this time, the reaction proceeds rapidly using a catalyst amount of 1.0 equivalent to about 1.0 equivalents of sodium carbonate, potassium carbonate, triethylamine, dimethylamine, and the like, and it is more preferable to use N, N-dimethylformamide, acetamide, dimethyl sulfoxide, etc. as a solvent. desirable. The following examples are intended to enable the present invention to be clearly understood and practiced, but not to limit the present invention. NMR spectra were recorded using an 80 MHz (Bruker) spectrometer and chemical shifts (Shift) were expressed in delta (ppm).
[실시예 1]Example 1
8-아자스피로[4.5]데칸-7,9-디온 소디움염8-azaspiro [4.5] decane-7,9-dione sodium salt
메틸렌클로라이드 50ml에 8-아자스피로[4.5]데칸-7,9-디온 8.35g을 넣어 용해시킨 후 소디움메톡시드용액(28%) 9.6ml를 적하시킨다. 실온에서 1시간 교반후 0-10℃로 냉각하여 표제의 화합물 9.1g(수율 96%)을 얻는다.After dissolving 8.35 g of 8-azaspiro [4.5] decane-7,9-dione in 50 ml of methylene chloride, 9.6 ml of sodium methoxide solution (28%) was added dropwise. After stirring for 1 hour at room temperature, the mixture was cooled to 0-10 DEG C to obtain 9.1 g (96% yield) of the title compound.
[실시예 2]Example 2
8-카복에톡시-8-아자스피로[4.5]데칸-7,9-디온8-carboxyethoxy-8-azaspiro [4.5] decane-7,9-dione
메틸렌클로라이드 50ml에 실시예 1에서 얻은 9.46g을 현탁시킨 후 에틸클로로포름에이트 5ml 적가시킨다. 0-10℃로 냉각한 후 10분간 교반시킨다. 메틸렌클로라이드층을 물 30ml로 세척한 후 무수황산마그네슘으로 건조시킨다. 여과하고 감압농축하여 표제의 화합물을 오일상으로 11.2g(수율 : 93.7%)을 얻는다.9.46 g of Example 1 was suspended in 50 ml of methylene chloride, and 5 ml of ethylchloroformate was added dropwise. Cool to 0-10 ° C. and stir for 10 minutes. The methylene chloride layer is washed with 30 ml of water and dried over anhydrous magnesium sulfate. Filtration and concentration under reduced pressure afforded 11.2 g (yield: 93.7%) of the title compound as an oil.
원소 분석 C12H17NO4(239.27)Elemental Analysis C 12 H 17 NO 4 (239.27)
이론치(%) : C ; 60.23%, H ; 7.16%, N ; 5.85%Theoretical value (%): C; 60.23%, H; 7.16%, N; 5.85%
실측치(%) : C ; 60.17%, H ; 7.17%, N ; 5.89%Found (%): C; 60.17%, H; 7.17%, N; 5.89%
NMR ; 4.2-4.4(q.2H), 2.6(s.4H), 1.5-1.8(m.8H)1.2-1.45(t.3H)NMR; 4.2-4.4 (q.2H), 2.6 (s.4H), 1.5-1.8 (m.8H) 1.2-1.45 (t.3H)
[실시예 3]Example 3
8-[4-[4-(2-피리미딜)-1-피페라지닐]부틸]-8-아자스피로[4.5]데칸-7,9-디온8- [4- [4- (2-pyrimidyl) -1-piperazinyl] butyl] -8-azaspiro [4.5] decane-7,9-dione
실시예 2에서 얻은 물질 4.785g과 1-(4-아미노부틸)-4-(2-피리미딜)피페라진 4.71g을 디멜틸설폭시드 30ml에 용해시킨 후 트리에틸아민 2.6ml를 첨가한다. 78-80℃에서 10시간 반응시키고 TLC로 반응이 완결되었음을 확인한후 실온으로 냉각하여 여과한다. 여액에 물 50ml와 톨루엔 30ml를 가한다. 10분간 교반후 물층을 제거하고 물 20ml로 2회 세척한다. 유기층에 진한염산 수용액 5ml와 물 40ml를 첨가하고 10분간 교반후 물층을 취하고 여기에 10% 수산화나트륨용액으로 알카리화한후 톨루엔 30ml로 2회 추출한다. 무수황산마그넴슘으로 건조시킨 뒤 물 70ml를 가하고 0-5℃로 냉각하여 1시간 교반시킨 후 여과하여 백색-미황색의 유리염기 6.63g(수율 : 86%)을 얻는다.4.785 g of the material obtained in Example 2 and 4.71 g of 1- (4-aminobutyl) -4- (2-pyrimidyl) piperazine are dissolved in 30 ml of dimethylsulfoxide, followed by addition of 2.6 ml of triethylamine. After reaction at 78-80 ° C for 10 hours, the reaction was completed by TLC, and then cooled to room temperature and filtered. 50 ml of water and 30 ml of toluene are added to the filtrate. After stirring for 10 minutes, the water layer was removed and washed twice with 20 ml of water. 5 ml of concentrated aqueous hydrochloric acid solution and 40 ml of water are added to the organic layer, and after stirring for 10 minutes, the water layer is taken, and after alkalinizing with 10% sodium hydroxide solution, it is extracted twice with 30 ml of toluene. After drying over anhydrous magnesium sulfate, 70 ml of water was added thereto, cooled to 0-5 ° C., stirred for 1 hour, and filtered to obtain 6.63 g (yield: 86%) of white-yellow yellow base.
mp 99°-120℃mp 99 ° -120 ℃
TLC (실리카겔/헥산 : 이소프로필알콜 : 암모니아스 = 6 : 10 : 1)TLC (silica gel / hexane: isopropyl alcohol: ammonia = 6: 10: 1)
Rf=0.6Rf = 0.6
[실시예 4]Example 4
8-[4-[4-(2-피리미딜)-1-피페라지닐]부틸]-8-아자스피로[4.5]데칸-7,9-디온 일염산염8- [4- [4- (2-pyrimidyl) -1-piperazinyl] butyl] -8-azaspiro [4.5] decane-7,9-dione monohydrochloride
실시예 3에서 얻은 유리염기 5.78g을 에탄올 30ml에 용해시키고 50-60℃에서 이소프로필알콜 포화 염화수소 용액을 1당량 적하시키고 서서히 실온으로 냉각하면 표제의 화합물이 결정으로 석출된다. 이것을 여과하여 건조하면 일염산염으로 5.95g(수율 94%)을 얻는다.5.78 g of the free base obtained in Example 3 was dissolved in 30 ml of ethanol, 1 equivalent of an isopropyl alcohol saturated hydrogen chloride solution was added dropwise at 50-60 ° C., and gradually cooled to room temperature to precipitate the title compound as crystals. This is filtered and dried to obtain 5.95 g (yield 94%) of monohydrochloride.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019870005273A KR890003811B1 (en) | 1987-05-27 | 1987-05-27 | Process for preparing n-(2-pyrimidyl) piperazinyl derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019870005273A KR890003811B1 (en) | 1987-05-27 | 1987-05-27 | Process for preparing n-(2-pyrimidyl) piperazinyl derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880013923A KR880013923A (en) | 1988-12-22 |
KR890003811B1 true KR890003811B1 (en) | 1989-10-05 |
Family
ID=19261682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870005273A KR890003811B1 (en) | 1987-05-27 | 1987-05-27 | Process for preparing n-(2-pyrimidyl) piperazinyl derivatives |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR890003811B1 (en) |
-
1987
- 1987-05-27 KR KR1019870005273A patent/KR890003811B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR880013923A (en) | 1988-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4029673A (en) | N-(1-benzyl pyrrolidinyl 2-alkyl) substituted benzamides and derivatives thereof | |
WO1994005628A1 (en) | Synthesis of 2-substituted quinazoline compounds (such as terazosin) and meobentine and bethanidine and intermediates therefor | |
PL215879B1 (en) | New method of industrial synthesis of tetra esters of 5-[bis(carboxyl methyl)amino]-3 -karboxymethyl-4-cyano-2-tio phenokarboxylic acid, method of manufacture of divalent salts of ranelic acid and their hydrates, as well as new intermediate compounds | |
US4032559A (en) | N,2-dicyanoacetimidates | |
US4067867A (en) | Process for preparing pyrazine precursor of methotrexate or an N-substituted derivative thereof and/or a di(lower)alkyl ester thereof | |
US5498711A (en) | Synthesis of 4,10-dinitro-2,6,8,12-tetraoxa-4,10-diazatetracyclo[5.5.0.05,903,11]dodecane | |
KR840001939B1 (en) | Process for preparing benzoguanamine derivatives | |
US3960856A (en) | Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide | |
KR890003811B1 (en) | Process for preparing n-(2-pyrimidyl) piperazinyl derivatives | |
BR0013750B1 (en) | INTERMEDIARIES FOR THE PRODUCTION OF NAPHTHRIDINE-3-CARBOXYLIC ACID DERIVATIVES | |
HU220971B1 (en) | Process for producing 0-(3-amino-2-hidroxy-propyl)-hidroxim acid halogenids | |
US4450274A (en) | Preparation of ethambutol-diisoniazide methane sulfonic acid salt | |
US4292431A (en) | Process for the production of hydroxymethylimidazoles | |
JPS6296481A (en) | Manufacture of n-sulfamyl-3- (2-guanidino-thiazole-4-yl-methylthio)-propioneamidine | |
SU900802A3 (en) | Process for preparing ethyleleiminocyanoazomethines | |
FR2597103A1 (en) | PROCESS FOR THE PREPARATION OF OXAZINOBENZOTHIAZINE 6,6-DIOXIDE DERIVATIVES | |
CA1171409A (en) | Arylazo compounds | |
KR940005959B1 (en) | Process for the preparation of aminobenzamide derivatives | |
US5106846A (en) | 2,3-thiomorpholinedione-2-oxime derivatives and pharmaceutical compositions containing them | |
CA1316940C (en) | Process for preparing substituted guanylthioureas | |
US5648490A (en) | Process for the preparation of 5-formylaminopyrimidines | |
SU753360A3 (en) | Method of preparing 6,7-dimethoxy-4-amino-2/4-(2-furoyl)-1-piperazinyl/-quinazoline | |
KR101170192B1 (en) | One-pot process for producing 1,2-benzisoxazole-3-methanesulfonamide | |
US3959372A (en) | Glyoxylic acid hydrazide-2-acylhydrazone compounds | |
KR20010030637A (en) | New process for producing aminopiperazine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19980814 Year of fee payment: 10 |
|
LAPS | Lapse due to unpaid annual fee |